Related Experiment Video
Updated: May 17, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
What we have learned from inherited platelet disorders
Sara J Israels1, Margaret L Rand
1Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada. israels@cc.umanitoba.ca
Pediatric Blood & Cancer
|October 31, 2012
Summary
Studying rare inherited platelet disorders reveals crucial insights into normal platelet function and biogenesis. Genetic analysis helps understand platelet receptors, granule release, and cytoskeleton assembly, impacting bleeding and clotting risks.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Inherited platelet disorders, though rare, offer unique insights into platelet physiology.
- Understanding these conditions requires correlating clinical and laboratory findings with specific genetic mutations.
Purpose of the Study:
- To elucidate the molecular underpinnings of inherited platelet disorders.
- To enhance comprehension of normal platelet biogenesis and function through studying disease mechanisms.
Main Methods:
- Phenotype-genotype association studies to link clinical presentation with genetic mutations.
- Analysis of platelet structure, function, and genetic variations.
- Genome-wide association studies (GWAS) to identify novel genes influencing platelet function.
Main Results:
- Detailed understanding of platelet membrane receptors, granule biogenesis/release, and cytoskeleton assembly.
- Identification of genetic polymorphisms affecting platelet adhesion and activation.
- Discovery of new genes associated with variations in normal platelet function through GWAS.
Conclusions:
- Molecular characterization of inherited platelet disorders significantly advances our knowledge of platelet physiology.
- Genetic factors play a critical role in determining individual risks for bleeding or thrombosis.
- Ongoing research continues to uncover novel genetic influences on platelet function.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:35Pedigree Analysis
Overview
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...